SCHEMBL1795644

SCHEMBL1795644

COc1ccc(S(=O)(=O)N2CC2c2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.71
KMT2A Q03164 2/20 0.71
RAB9A P51151 2/20 0.71
LMNA P02545 5/20 0.62
RECQL P46063 2/20 0.62
KDM4E B2RXH2 1/20 0.62
TSHR P16473 1/20 0.62
MAPT P10636 4/20 0.59
SMN1; SMN2 Q16637 1/20 0.57
TAS2R14 Q9NYV8 1/20 0.56
HSD11B1 P28845 1/20 0.53
MEN1 O00255 1/20 0.52
PKM P14618 2/20 0.51
NPC1 O15118 1/20 0.51
PKLR P30613 1/20 0.51
MMP1 P03956 3/20 0.49
MMP3 P08254 3/20 0.49
MMP7 P09237 2/20 0.49
MMP9 P14780 2/20 0.49
MMP13 P45452 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17961631 0.87 LMNA (0.64) ALDH1A1KMT2ARAB9ALMNARECQL
SCHEMBL12615015 0.84 ALDH1A1 (1.00) ALDH1A1KMT2ARAB9ALMNATSHR
SCHEMBL17970866 0.83 ALDH1A1 (0.78) ALDH1A1KMT2ARAB9ALMNATSHR
SCHEMBL931458 0.83 ALDH1A1 (0.78) ALDH1A1KMT2ARAB9ALMNATSHR
SCHEMBL17368844 0.83 ALDH1A1 (0.68) ALDH1A1KMT2ARAB9ALMNARECQL
SCHEMBL5252168 0.80 ALDH1A1 (1.00) ALDH1A1KMT2ARAB9AHSD11B1MEN1
SCHEMBL28969725 0.79 PSEN1 (0.62) ALDH1A1KMT2ARAB9ALMNASMN1; SMN2
SCHEMBL17371677 0.78 KMT2A (0.73) ALDH1A1KMT2ARAB9ATAS2R14MEN1
SCHEMBL31004048 0.77 ALDH1A1 (0.78) ALDH1A1KMT2ARAB9ALMNATSHR
SCHEMBL1792200 0.77 ALDH1A1 (0.71) ALDH1A1KMT2ARAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459385-A Method for synthesizing 2-phenyl-1- (phenylsulfonyl) aziridine compound 常州大学 2024-08-09 CN disclosed
CN-112608269-B Method for catalytically synthesizing pyrrolidine by weak interaction of chalcogen 山东大学 2022-05-06 CN disclosed
CN-112608269-A Method for catalytically synthesizing pyrrolidine by weak interaction of chalcogen 山东大学 2021-04-06 CN disclosed
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides UNIVERSITY OF SOUTH FLORIDA (US) 2011-05-12 US disclosed
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides UNIVERSITY OF SOUTH FLORIDA (US) 2011-05-12 US disclosed
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides UNIVERSITY OF SOUTH FLORIDA (US) 2011-05-12 US disclosed
WO-2009146032-A2 METAL PORPHYRIN CATALYZED OLEFIN AZIRIDINATION WITH SULFONYL AZIDES UNIVERSITY OF SOUTH FLORIDA (US) 2009-12-03 WO disclosed
WO-2009146032-A2 METAL PORPHYRIN CATALYZED OLEFIN AZIRIDINATION WITH SULFONYL AZIDES UNIVERSITY OF SOUTH FLORIDA (US) 2009-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides PPOX, SOD1, AP1S1 ALDH1A1 1473/4885KMT2A 3295/4885RAB9A 1892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.